Modification of the human genome: Human rights challenges raised by scientific and technical developments Jonathan Montgomery, Professor of Health Care.

Slides:



Advertisements
Similar presentations
The Right to Enjoy the Benefits of Scientific Progress State Obligations Yvonne Donders Amsterdam Center for International Law.
Advertisements

4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
Chapter 19 Issues and Ethics Identifying an Issue Issue: a subject or problem that has more than one point of view Somatic Cells: cells that compose.
What to Provide to OMB History of the rule Problem to be addressed –Quantitative and qualitative analysis “Significant Regulatory Action” under 12866(3)(f)
Integrating Ethics in EU Research
Predictive Testing & Insurance Law. Content of the Presentation: A. Predictive Tests B. Benefits of Predictive Testing C. Drawbacks of Predictive Testing.
Translation of Stem Cells therapies: How to Balance Hope and Uncertainties? E. Rial-Sebbag and A. Blasimme.
The European Research Council
Oviedo Convention and Its Protocols – Impact on Polish Law International Bioethics Conference Oviedo Convention in Central and Eastern European Countries.
Identifying Human Rights The protections offered by the ECHR and the Human Rights Act 1998 Brayne & Carr: Law for Social Workers: 10e Chapter 3.
Responsible Stewardship: Choices and Challenges in Preventing the Malign Use of the Life Sciences Brian Rappert.
Health research and the protection of personal information rights in international ethics and human rights law Colin M Harper Promoting Health Research.
EPHA EGM 2/12/2002 A definition of health A state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.
The Eighth Asian Bioethics Conference Biotechnology, Culture, and Human Values in Asia and Beyond Confidentiality and Genetic data: Ethical and Legal Rights.
Current Challenges in Women’s Health Care and Medical Research 7 December 2011 Cairo 7 December 2011 Cairo Orio Ikebe UNESCO Cairo Office Orio Ikebe UNESCO.
Dr. Igor Codreanu Center of Dialysis and Renal Transplant Republican Clinical Hospital, Chisinau THE IMPACT OF THE OVIEDO CONVENTION ON LEGISLATION IN.
The French Perspective The law 1994 Civil code: Art
A QUESTION OF FAITH: RELIGION AND BELIEF IN EUROPE Equinet LWG 2011 Jayne Hardwick Moderator Equinet – Legal Working Group.
1 Impact of the Oviedo Convention and its Protocols on Legislation and Practices in Slovenia Joze Trontelj.
1 Additional Protocol to the Oviedo Convention concerning Genetic Testing for Health Purposes Laurence Lwoff Bioethics Division Council of Europe 6th Meeting.
ETHICAL ISSUES AND INFORMED CONSENT Juan M. Lozano, MD, MSc Department of Paediatrics and Clinical Epidemiology Unit School of Medicine, Javeriana University.
Bioethics as a Governance Practice Health Ethics and Law Annual Lecture 2015 Jonathan Montgomery Professor of Health Care Law, UCL Chair, Nuffield Council.
Other Human Rights instruments for persons with disabilities in Turkey and the Western Balkans: CEDAW Ana Pelaez UNITED NATIONS COMMITTEE ON THE RIGHTS.
Genome editing: What lessons can we learn from the mitochondrial donation debate? Peter Thompson Human Fertilisation & Embryology Authority.
Funding and patentability of stem cell research in the European Union - A critical legal review of European legislation Dr. Malene Rowlandson, University.
Research Ethics Dr Nichola Seare Aston Health Research & Innovation Cluster.
1 Dr David Coles Ethics and Science European Commission ACTIVITIES on ETHICS in The Science and Society Programme.
Developments of Bioethics in Europe and Lithuania
A capacity building programme for patient representatives
Convention on Human Rights and Biomedicine
Additional Protocol to the Oviedo Convention concerning Transplantation of Organs and Tissues of Human Origin Javier Arias-Diaz.
Honours Seminar in Psychology
ART symposium: comment on sessions
Lesson 4: The U.S. Constitution
Lesson Overview 1.2 Science in Context.
Week 5: Ethical, Legal & Social Issues in Applied Genomics
Evidence-based Medicine
Gene Editing: Ethics and Governance
Data Protection: EU & International
On Human Gene Editing: International Summit Statement
Fundamentals of Ethics
An Ethic of Integration: Novel Biotechnologies and Human Dignity
20th anniversary of the Oviedo Convention Relevance and Challenges
Data Protection & Human Rights
Lesson Overview 1.2 Science in Context.
Dan Tofan | Expert in NIS 21st Art. 13a WG| LISBON |
Discrimination on the basis of disability
Ethics in Research.
General Principles and Problems of Convention Law
Chapter 10Ethical Issues in Health Care
Case C-528/16 on Mutagenesis
Information technologies/NBIC and Big data
Identifying Basic Principles for Moving Forward
27 Nov, 2018 The University of Hong Kong
Regulation of Gene Therapy Products and Gametes Research in Hong Kong
Lesson Overview 1.2 Science in Context.
Lesson Overview 1.2 Science in Context.
Lesson Overview 1.2 Science in Context.
Lesson Overview 1.2 Science in Context.
Lesson Overview 1.2 Science in Context.
Public Privacy: juridical & ethical perspective
Ethical and Policy Issues in Human Germ line Modifications
Lesson Overview 1.2 Science in Context.
FUNDAMENTAL SOCIAL RIGHTS IN EU
Lesson Overview 1.2 Science in Context.
GENOMICS AND HUMAN RIGHTS
Chapter 10 Ethical Issues in Health Care
Chapter 10 Ethical Issues in Health Care
Lesson Overview 1.2 Science in Context.
Autonomy Challenges raised by the evolution of practices for children's rights Kavot Zillén.
Presentation transcript:

Modification of the human genome: Human rights challenges raised by scientific and technical developments Jonathan Montgomery, Professor of Health Care Law Jonathan.Montgomery@ucl.ac.uk

‘Deliberate germline editing in human beings would cross a line viewed as ethically inviolable.’ R2115 (2017) An intervention seeking to modify the human genome may only be undertaken for preventive, diagnostic or therapeutic purposes and only if its aim is not to introduce any modification in the genome of any descendants. (Oviedo Art 13) ‘Echoes a wide international consensus’ Rogers & de Bousingen Bioethics in Europe (1995) p 93

The need for an ‘affirmative genealogy’ ‘opens our minds to the way in which historically embodied meaning calls upon us.‘ Hans Joas The Sacredness of the Person (2013) Living documents not originalist fundamentalism Human Rights conventions have specific histories Experts, politicians, publics ‘Value generalisation’ Premature harmonisation? Acceptable margins of appreciation (subsidiarity) Three concerns Pluralism, Relativism, Nihilism (mere ’fiat’)

A genealogy of Art 13: long-standing concerns over… Absolutism ‘exceptional cases (where there is no conceivable alternative) in order to correct recognised abnormalities provided that it is carried out for the purpose of ending of alleviating severe human suffering and that strict standards of reliability and safety are observed.’ (Dec 1992) With regulatory oversight from ‘an independent body, preferably a national ethics committee’ Rejected with unanimous agreement on need for periodic review (5 years discussed) Attempt to insert ‘given the current state of scientific knowledge’ rejected

... Unintended consequences Steering Committee considered risk that cancer treatments with side effects that interfered with germline (1993) Intentions rather than objective effects to address this (1994) Compare objective test offered in 1995 ‘without any intervention in the germ-line’ Assumed that this was assessable because there would be oversight from research ethics committees (1994) Assumed the article would be reviewed (1994)

Language and explanations are unstable ‘Genome’ not ’germ cell line’ ‘Intervention’, ’modification’ not ‘interference’ Now ‘editing’ Not ‘engineering’ R934 (1982) ‘Aim’ to ‘unforeseen side-effects’ and ‘intention’ (explanatory report) Art 13 proposed ‘owing to this uncertainty’ about effects ‘Right to inherit a genetic inheritance that has not been artificially changed’ but with exceptions ‘for example in the field of therapeutic applications’ R934 (1982) based on Arts 2 & 3 ECHR

Human Rights Challenges to denial of access to germ-line therapies Equitable access (Art 3), non-discrimination (Art 11) Private life (ECHR Art 8) engaged and legitimate competing interests must be balanced, fairly and not arbitrarily Blanket bans deny chance to balance Benefits of advances must be available to all (UNESCO Universal Declaration on the Human Genome and Human Rights 1997, Art 12) Progress should be available to ‘future generations’ and ‘all humanity’ (Oviedo preamble) Holding on to the ‘germ-line prohibition is an example of ‘the interest of society’ prevailing over the individual in breach of Art 2 of Oviedo

Time for ‘broad and informed public debate’… Need to clarify the principle behind Art 13 It is not obviously a germ-line rule Need to clarify interplay between individual rights to use therapies and public heath and morals in the light of current scientific understanding Find ways to integrate political, expert, and public opinions into a mature deliberation Consistent with the expectations of those who produced Oviedo and with Arts 28, 31 and possibly 32